Curis Analyst Ratings
Curis Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/29/2023 | 612.33% | HC Wainwright & Co. | $6 → $51 | Reiterates | Buy → Buy |
| 09/25/2023 | -16.2% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy |
| 09/07/2023 | -58.1% | Cantor Fitzgerald | → $3 | Reiterates | Overweight → Overweight |
| 08/04/2023 | -16.2% | HC Wainwright & Co. | → $6 | Reiterates | Buy → Buy |
| 07/11/2023 | -58.1% | Cantor Fitzgerald | → $3 | Reiterates | Overweight → Overweight |
| 07/07/2023 | -16.2% | HC Wainwright & Co. | $9 → $6 | Maintains | Buy |
| 05/05/2023 | 25.71% | HC Wainwright & Co. | → $9 | Reiterates | → Buy |
| 11/10/2022 | 25.71% | HC Wainwright & Co. | $16 → $9 | Maintains | Buy |
| 04/05/2022 | 39.67% | B. Riley Securities | $22 → $10 | Maintains | Buy |
| 04/05/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 10/13/2021 | 109.51% | Raymond James | → $15 | Initiates Coverage On | → Outperform |
| 03/25/2021 | 165.38% | B. Riley Securities | → $19 | Initiates Coverage On | → Buy |
| 01/15/2021 | 123.48% | HC Wainwright & Co. | $9 → $16 | Maintains | Buy |
| 12/08/2020 | 25.71% | HC Wainwright & Co. | $5 → $9 | Maintains | Buy |
| 11/24/2020 | -30.16% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
| 07/17/2020 | -44.13% | Cantor Fitzgerald | → $4 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/29/2023 | 612.33% | HC Wainwright公司 | $6→$51 | 重申 | 購買→購買 |
| 09/25/2023 | -16.2% | HC Wainwright公司 | →$6 | 重申 | 購買→購買 |
| 09/07/2023 | -58.1% | 康託·菲茨傑拉德 | →$3 | 重申 | 超重→超重 |
| 08/04/2023 | -16.2% | HC Wainwright公司 | →$6 | 重申 | 購買→購買 |
| 07/11/2023 | -58.1% | 康託·菲茨傑拉德 | →$3 | 重申 | 超重→超重 |
| 07/07/2023 | -16.2% | HC Wainwright公司 | $9→$6 | 維護 | 買 |
| 05/05/2023 | 25.71% | HC Wainwright公司 | →$9 | 重申 | →購買 |
| 2022年11月10日 | 25.71% | HC Wainwright公司 | $16→$9 | 維護 | 買 |
| 04/05/2022 | 39.67% | B.萊利證券 | $22→$10 | 維護 | 買 |
| 04/05/2022 | - | 雷蒙德·詹姆斯 | 評級下調 | 跑贏→市場表現 | |
| 10/13/2021 | 109.51% | 雷蒙德·詹姆斯 | →$15 | 開始承保 | →跑贏大盤 |
| 03/25/2021 | 165.38% | B.萊利證券 | →$19 | 開始承保 | →購買 |
| 2021/01/15 | 123.48% | HC Wainwright公司 | $9→$16 | 維護 | 買 |
| 12/08/2020 | 25.71% | HC Wainwright公司 | $5→$9 | 維護 | 買 |
| 11/24/2020 | -30.16% | HC Wainwright公司 | →$5 | 開始承保 | →購買 |
| 07/17/2020 | -44.13% | 康託·菲茨傑拉德 | →$4 | 開始承保 | →超重 |
What is the target price for Curis (CRIS)?
Curis(CRIS)的目標價是多少？
The latest price target for Curis (NASDAQ: CRIS) was reported by HC Wainwright & Co. on September 29, 2023. The analyst firm set a price target for $51.00 expecting CRIS to rise to within 12 months (a possible 612.33% upside). 8 analyst firms have reported ratings in the last year.
納斯達克(納斯達克代碼：CRIS)的最新目標價是由HC Wainwright&Co.於2023年9月29日報道的。這家分析公司將目標價定為51美元，預計CRI將在12個月內升至(可能上漲612.33)。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Curis (CRIS)?
Curis(CRIS)的最新分析師評級是多少？
The latest analyst rating for Curis (NASDAQ: CRIS) was provided by HC Wainwright & Co., and Curis reiterated their buy rating.
納斯達克(Sequoia Capital：CRIS)的最新分析師評級由HC Wainwright&Co.提供，Curis重申其買入評級。
When is the next analyst rating going to be posted or updated for Curis (CRIS)?
Curis(CRIS)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Curis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Curis was filed on September 29, 2023 so you should expect the next rating to be made available sometime around September 29, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Curis的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Curis的上一次評級是在2023年9月29日提交的，所以你應該預計下一次評級將在2024年9月29日左右提供。
Is the Analyst Rating Curis (CRIS) correct?
分析師評級Curis(CRIS)正確嗎？
While ratings are subjective and will change, the latest Curis (CRIS) rating was a reiterated with a price target of $6.00 to $51.00. The current price Curis (CRIS) is trading at is $7.16, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Curis(CRIS)評級被重申，目標價在6.00美元至51.00美元之間。目前Curis(CRIS)的交易價格為7.16美元，在分析師的預測範圍內。
譯文內容由第三人軟體翻譯。